Antiglaucoma medication and clinical depression

Australian and New Zealand Journal of Psychiatry

Volumn 35, Issue 5, 2001, Pages 569-571

  Schweitzer, I ^a   Maguire, K ^a   Tuckwell, V ^a  

^a NONE   (Australia)

Author keywords

Beta blockers; Betaxolol; Depression; Topical

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; EYE DROPS; FLUOXETINE; LATANOPROST; LITHIUM; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGED; AGITATION; ANHEDONIA; ANOREXIA; ARTICLE; CASE REPORT; CONFUSION; DEPRESSION; ELECTROCONVULSIVE THERAPY; ENERGY; GLAUCOMA; HUMAN; LIBIDO; MALE; MEMORY; MOOD; OBSESSION; PSYCHOSOCIAL WITHDRAWAL; SLEEP DISORDER; SYMPTOM; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; BETAXOLOL; DEPRESSIVE DISORDER, MAJOR; GLAUCOMA; HUMANS; MALE; OPHTHALMIC SOLUTIONS; RECURRENCE; SYMPATHOLYTICS;

EID: 0034768336     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2001.00929.x     Document Type: Article

References (10)

1. Systemic effects of topical ophthalmic β-adrenoceptor antagonists
2. Adverse effects experienced by patients taking timolol
3. Psychiatric side-effects from topical ocular timolol, a beta-adrenergic blocker
4. Depression and topical ophthalmic beta adrenergic blockade
5. Clinical depression associated with betaxolol
6. β-blockers and depression
7. Current concepts of mechanisms of action of antidepressant treatments based on preclinical studies
8. Pindolol binding to 5HT1A receptors in human brain confirmed with positron emission tomography
9. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5HT) in the frontal cortex of freely-moving rats by (-) -pindolol alone and in association with 5HT reuptake inhibitors: Comparative roles of 5-HT1A, and 5-HT1B receptors
10. Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops: Potential for oral-ophthalmic drug interaction